PSMA PET/CT SUVmax as a prognostic biomarker in patients with metachronous metastatic hormone-sensitive prostate cancer (mHSPC)


Por: Henriquez I, Malave B, Campos F, Hidalgo E, Muelas R, Ferrer C, Munoz-Rodriguez J, Villamon A, Pascual M, Badia J, Fuertes J, Hinojosa-Salas P

Publicada: 1 feb 2025 Ahead of Print: 1 jul 2024
Resumen:

ISSN: 1699048X





CLINICAL & TRANSLATIONAL ONCOLOGY
Editorial
SPRINGER-VERLAG ITALIA SRL, VIA DECEMBRIO, 28, MILAN, 20137, ITALY, Italia
Tipo de documento: Article
Volumen: 27 Número: 2
Páginas: 706-715
WOS Id: 001280263200001
ID de PubMed: 39073734

MÉTRICAS